Our relationship with the John Theurer Cancer Center
Contributions to the Eileen Fund go to the research division at Hackensack University Medical Center to support efforts to find the underlying causes of cancer, so they cannot only cure the illness upon detection, but also stop it from returning in any form.
John Theurer Cancer Center
part of Hackensack Meridian Health
John Theurer Cancer Center at Hackensack University Medical Center is New Jersey’s largest and most comprehensive cancer program. In less than 25 years, we’ve become one of the most prominent programs nationwide, with more than 1,200 team members collaborating in a highly subspecialized and multidisciplinary environment.
More people in the New Jersey/New York metropolitan area turn to John Theurer Cancer Center for cancer care each year than to any other facility in New Jersey for our:
• Comprehensive bone marrow and stem cell transplant program
• Robust clinical trial portfolio
• Expertise in the management of hematologic malignancies in adults and children
• Minimally invasive surgery and advanced radiation oncology approaches
• Value-based care to improve clinical outcomes and reduce cancer-care costs
A Quarter Century of Progress…
More than 6,500 Bone Marrow Transplants
Since our first autologous bone marrow transplant in 1990 and the opening of New Jersey’s only pediatric bone marrow transplant center, our center has grown to become the largest BMT program in the Tri-State area. We perform well over 400 transplants annually (including about 25 pediatric cases) — in addition to our new BMT program, which opened at Georgetown in 2014 in Washington, DC.
• Our joint adult-pediatric BMT program is FACT-accredited.
• We have one of the largest allogeneic BMT programs and one of the biggest programs in the country for multiple myeloma, with over 250 transplants a year.
• Our dedicated pediatric photophoresis program was created to treat acute and chronic graft-versus-host disease.
• Pediatric patients with sickle cell disease benefit from one of the largest BMT programs in the nation for treating this illness and other noncancerous hematologic disorders.
Leaders in the Management of Myeloma and Other Hematologic Cancers
John Theurer Cancer Center is one of the few centers in the country — and the first in New Jersey — to offer CAR T-cell therapy, a revolutionary immunotherapy for young patients with acute lymphoblastic leukemia and some adults with large B-cell lymphoma. White blood cells are removed from the patient, modified in the laboratory to recognize cancer cells, grown to larger amounts, and returned to the patient to kill cancer cells. CAR T-cell therapy is an intensive treatment that requires specialized expertise and resources to support the patients who receive it. Many of our cancer specialists have exceptionally strong backgrounds in immunology and are well-equipped to support patients who develop the side effects of CAR T-cell therapy.
Housed within a 775 bed, not-for-profit, teaching, tertiary care, and research hospital, John Theurer Cancer Center provides state-of-the-art technological advances, compassionate care, research innovations, medical expertise, and a full range of aftercare services that distinguish John Theurer Cancer Center from other facilities.
ABOUT HACKENSACK MERIDIAN HEALTH
Hackensack Meridian Health is a leading not-for-profit health care organization that is the largest, most comprehensive and truly integrated health care network in New Jersey, offering a complete range of medical services, innovative research and life-enhancing care.
Hackensack Meridian Health hospitals
Hackensack Meridian Health comprises 17 hospitals, including three academic medical centers, two children’s hospitals and nine community hospitals, two rehabilitation hospitals, more than 500 patient care sites and physician offices. Hackensack Meridian Health has 34,000 team members, more than 6,500 physicians and is a distinguished leader in health care philanthropy, committed to the health and well-being of the communities it serves.
The Network’s notable distinctions include having one of only five major academic medical centers in the nation to receive Healthgrades America’s 50 Best Hospitals Award for five or more consecutive years, four hospitals ranked among the top 10 in New Jersey as ranked by U.S. News and World Report. Other honors include consistently achieving Magnet® recognition for nursing excellence from the American Nurses Credentialing Center, recipient of the John M. Eisenberg Award for Patient Safety and Quality from The Joint Commission and the National Quality Forum, a six-time recipient of Fortune’s “100 Best Companies to Work For,” one of the “20 Best Workplaces in Health Care” in the nation, and the number one “Best Place to Work for Women.” Hackensack Meridian Health is a member of AllSpire Health Partners, an interstate consortium of leading health systems, to focus on the sharing of best practices in clinical care and achieving efficiencies.
For additional information, please visit www.HackensackMeridianHealth.org.
David & Alice Jurist Institute for Research at Hackensack University Medical Center
In 2016, David & Alice’s daughter Eileen lost her battle with cancer. In Eileen’s memory and in her honor, they started The Eileen Fund.
The David and Alice Jurist Institute for Research at Hackensack University Medical Center in New Jersey was named for David and Alice Jurist because of their commitment to children with cancer.